Barclays Maintains Overweight on Encompass Health, Lowers Price Target to $109
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Andrew Mok maintains an Overweight rating on Encompass Health (NYSE:EHC) but lowers the price target from $113 to $109.
August 06, 2024 | 1:35 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Barclays analyst Andrew Mok maintains an Overweight rating on Encompass Health but lowers the price target from $113 to $109.
The Overweight rating suggests a positive outlook, but the lowered price target indicates some caution. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100